Amphastar Pharmaceuticals
AMPH
AMPH
135 hedge funds and large institutions have $591M invested in Amphastar Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 43 increasing their positions, 38 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5.22% more ownership
Funds ownership: 51.79% → 57.01% (+5.2%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2.36M
Holders
135
Holding in Top 10
–
Calls
–
Puts
$2.36M
Top Buyers
| 1 | +$18.3M | |
| 2 | +$11.8M | |
| 3 | +$9.09M | |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
+$5.85M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$3M |
Top Sellers
| 1 | -$5.11M | |
| 2 | -$3.81M | |
| 3 | -$3.03M | |
| 4 |
Morgan Stanley
New York
|
-$2.52M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$2.24M |